RYSE Asset Management Overview
Founded in 2017 and headquartered in London, RYSE Asset Management is a leading venture capital firm driving the future of healthcare through HealthTech innovation. The firm focuses on investing in early-stage companies, typically at the Seed and Series A stages, that address unmet clinical needs, improve access, and make healthcare more affordable. RYSE collaborates with industry leaders like DigitalHealth.London, the NHS, Novartis, and Medtronic to bridge the gap between visionary ideas and real-world impact. Their investment areas include digital diagnostics, digital therapeutics, medical devices, and data and discovery platforms, with expertise in cardiovascular health, metabolic disorders, oncology, mental health, women's health, and health AI.
Is RYSE Asset Management the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with RYSE Asset Management, along with a list of other relevant VCs, is available on Hopohopo.io.
RYSE Asset Management
Investment focus
Product type
- Software
- Hardware
- Drugs / Pharma
Industries / verticals
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
Stages
Seed, Series A
First ticket size
US$100,000 - US$1,500,000
How to approach funds like RYSE Asset Management
When approaching RYSE Asset Management, founders should highlight robust clinical validation and a clear pathway to integration within healthcare systems, especially the NHS. Demonstrate traction with key opinion leaders or pilot programs, and articulate how your solution addresses systemic barriers to adoption in the UK and Europe. Emphasize your ability to navigate regulatory environments and your strategy for scaling impact in partnership with established healthcare stakeholders.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
